Scholars Central

Conference abstractPublished 7 Sep 2023

Direct oral anticoagulants (DOACs) in patients with atrial fibrillation (AF): monitoring of adherence to therapy

Authors: Cannavale A, Pannone B, Iannuzzi R, Fortunato F, Coronella C, Serafino G, Laccetti M

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background Patients with AF have a high risk of developing a stroke ischemic when untreated, for this the evaluation of persistence of the DOACS is essential to understand to what extent patients benefit from preventive treatment, tolerating possible adverse effects. Clinical studies show that about 40-60% of patients on long-term DOAC therapy has a nonoptimal adherence rate, with percentages increasing proportionally to the duration of treatment. Many causes have been identified: the patient's clinical background, socio-economic and educational level, psychological state, and, last but not least, the quality of the doctorpatient relationship, influence adherence to treatment with DOACs. Materials In an outpatient clinic dedicated to the follow-up of patients with atrial fibrillation discharged from our COU, we examined adherence to therapy over a 24-month period with six-monthly check-ups at 6, 12, 18 and 24 months from the start of the anticoagulant treatment. Medication adherence was measured using the Morisky Medication Adherence Scale (MMAS-8): a score of 8 was classified as high adherence while scores below 8 were considered as suboptimal adherence. Enrolled patients completed various questionnaires through which their awareness of the need for anticoagulant therapy, the risks and benefits of DOACs, any practical problems, and perceived quality of life during therapy were tested. The analysis involved 49 patients, mean age 70.6 ± 9.2 years, the majority male, equally distributed for the 4 oral anticoagulants: dabigatran (11), apixaban (14), rivaroxaban (12), and edoxaban (12). Conclusions Overall, 12 patients were not fully adherent to anticoagulant treatment (24%): dabigatran (5), apixaban (4), rivaroxaban (2), edoxaban (1): in particular, subjects who received conflicting information on their condition clinical or treatment-related health care professionals were more likely to fail to take their medication correctly, as were those who perceived they were not involved in the decision-making process. Another determining factor was identified in the number of drugs that the patient took daily, in consideration of the greater number of nonadherents in the groups that took DOACS in double daily administration. Our data confirm those reported in the literature. PDF HTML

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Health Science Journal.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalHealth Science Journal
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Cannavale A”
  • BylineArticles whose byline prints “Pannone B”
  • BylineArticles whose byline prints “Iannuzzi R”
  • BylineArticles whose byline prints “Fortunato F”
  • BylineArticles whose byline prints “Coronella C”
  • BylineArticles whose byline prints “Serafino G”
  • BylineArticles whose byline prints “Laccetti M”